Monashee Investment Management LLC Liquidia Corp Transaction History

Monashee Investment Management LLC

  • $704 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$4.34 - $8.28 $1.95 Million - $3.73 Million
-450,000 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$4.86 - $11.44 $2.19 Million - $5.15 Million
450,000 New
450,000 $3.79 Million
Q2 2019

Aug 07, 2019
SELL
$7.92 - $11.39 $792,000 - $1.14 Million
-100,000 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$10.82 - $21.79 $1.08 Million - $2.18 Million
100,000 New
100,000 $1.14 Million

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email